Seeing Is Believing

Currently out of the existing stock ratings of Ann Hynes, 207 are a HOLD (36.44%), 361 are a BUY (63.56%).
Analyst Ann Hynes, currently employed at MIZUHO, carries an average stock price target met ratio of 72.09% that have a potential upside of 13.71% achieved within 177 days.
Ann Hynes’s has documented 1,088 price targets and ratings displayed on 36 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on SGRY, Surgery Partners at 05-Mar-2026.
Analyst best performing recommendations are on PPD (PPD).
The best stock recommendation documented was for DPLO (DIPLOMAT PHARMACY) at 11/7/2017. The price target of $20 was fulfilled within 1 day with a profit of $1.25 (6.67%) receiving and performance score of 66.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 03-Mar-2026
$20
$-5.62 (-21.94%)
$27
7 days ago
(03-Mar-2026)
6/19 (31.58%)
$-3.44 (-14.68%)
111
Hold Since 03-Dec-2025
$22
$-3.62 (-14.13%)
$14
12 days ago
(26-Feb-2026)
10/14 (71.43%)
$1.16 (5.57%)
343
Buy Since 12-Dec-2022
$28
$2.38 (9.29%)
$17
12 days ago
(26-Feb-2026)
3/15 (20%)
$7.16 (34.36%)
78
Buy Since 09-Apr-2025
$22
$-3.62 (-14.13%)
$27
15 days ago
(23-Feb-2026)
1/4 (25%)
$5.21 (31.03%)
4
Hold Since 22-Jan-2026
$15
$-10.62 (-41.45%)
$105
1 months 16 days ago
(22-Jan-2026)
19/21 (90.48%)
$-0.15 (-0.99%)
1043
Which stock is Ann Hynes is most bullish on?
Which stock is Ann Hynes is most reserved on?
What Year was the first public recommendation made by Ann Hynes?